Marino Stram & Associates’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-15
Closed -$3K 545
2018
Q1
$3K Sell
15
-80
-84% -$13.4K ﹤0.01% 425
2017
Q4
$16K Buy
+95
New +$17K 0.01% 278

Other funds holding AGN

Marino Stram & Associates's AGN Position: Q2 2018 in Review

Marino Stram & Associates sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 15 shares — an estimated $3K sold.

Marino Stram & Associates first reported a position in AGN in Q4 2017 and held it in 2 quarters. The position peaked at $16K in Q4 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Marino Stram & Associates reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Marino Stram & Associates sold 15 Allergan plc shares in Q2 2018, an estimated $3K.
  • Marino Stram & Associates first reported a position in Allergan plc in Q4 2017 and held it in 2 quarters.
  • Marino Stram & Associates's Allergan plc position peaked at $16K in Q4 2017.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Marino Stram & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.